Ebpay生命医药出版社
  • Ebpay生命

    102445

    论文已发表

    提 交 论 文


    注册即可获取Ebpay生命的最新动态

    注 册



    IF 收录期刊



    • 3.3 Breast Cancer (Dove Med Press)
    • 3.4 Clin Epidemiol
    • 2.5 Cancer Manag Res
    • 2.9 Infect Drug Resist
    • 3.5 Clin Interv Aging
    • 4.7 Drug Des Dev Ther
    • 2.7 Int J Chronic Obstr
    • 6.6 Int J Nanomed
    • 2.5 Int J Women's Health
    • 2.5 Neuropsych Dis Treat
    • 2.7 OncoTargets Ther
    • 2.0 Patient Prefer Adher
    • 2.3 Ther Clin Risk Manag
    • 2.5 J Pain Res
    • 2.8 Diabet Metab Synd Ob
    • 2.8 Psychol Res Behav Ma
    • 3.0 Nat Sci Sleep
    • 1.8 Pharmgenomics Pers Med
    • 2.7 Risk Manag Healthc Policy
    • 4.2 J Inflamm Res
    • 2.1 Int J Gen Med
    • 4.2 J Hepatocell Carcinoma
    • 3.7 J Asthma Allergy
    • 1.9 Clin Cosmet Investig Dermatol
    • 2.7 J Multidiscip Healthc



    更多详情 >>





    已发表论文

    奥利西汀联合丙泊酚用于无痛宫腔镜检查的有效剂量:一项前瞻性剂量探索研究

     

    Authors Gao L, Tan A, Wang Z, Wei L, Wang X

    Received 18 February 2025

    Accepted for publication 15 May 2025

    Published 21 May 2025 Volume 2025:18 Pages 2651—2657

    DOI http://doi.org/10.2147/IJGM.S523428

    Checked for plagiarism Yes

    Review by Single anonymous peer review

    Peer reviewer comments 2

    Editor who approved publication: Dr Woon-Man Kung

    Liangliang Gao,1,* Aiping Tan,1,* Zehui Wang,2 Lei Wei,1 Xingshuang Wang1 

    1Department of Anesthesiology, Suzhou Hospital Affiliated to Nanjing Medical University, Suzhou, People’s Republic of China; 2Department of Anesthesiology, Cixi People’s Hospital, Cixi, People’s Republic of China

    *These authors contributed equally to this work

    Correspondence: Xingshuang Wang, Department of Anesthesiology, Suzhou Hospital Affiliated to Nanjing Medical University, No. 26, Daoqian Street, Suzhou, 215000, People’s Republic of China, Email wangshshyaoff@126.com

    Background: The combination of oliceridine with propofol represents a new option for complete intravenous anesthesia in painless hysteroscopy. The purpose of this study was to determine the 95% effective dose (ED95) and the median effective dose (ED50) of oliceridine when combined with propofol for painless hysteroscopy.
    Methods: A total of 29 patients, aged between 18 and 60 years and classified as American Society of Anesthesiologists (ASA) I–II, were initially recruited for hysteroscopy. Subsequently, 26 of these patients were included in the final analysis. Before surgery, an intravenous dose of 0.02 mg/kg oliceridine, with a dose gradient of 0.002 mg/kg, was administered using Dixon’s up-and-down method. Two minutes later, 2 mg/kg of propofol was administered. The oliceridine dosage for the following patient was increased by 0.002 mg/kg if the hysteroscopy failed (defined as poor cervical dilatation, problematic hysteroscopic placement, or a Ramsay Sedation Scale (RSS) score < 5 or any movement and frowning by the patient within 5 minutes). In contrast, the dosage was decreased by 0.002 mg/kg. At least seven crossovers had to occur before the test was stopped. The ED50 and ED95 of oliceridine in combination with propofol for hysteroscopy were determined using the probit analysis method.
    Results: The ED50 and ED95 of oliceridine with 95% CI were 0.0192 (0.0183– 0.0216) mg/kg and 0.0237 (0.0214– 0.0415) mg/kg, respectively. No patients experienced significant adverse effects.
    Conclusion: The study determined that the ED50 and ED95 of oliceridine in combination with propofol for painless hysteroscopy are 0.0192 mg/kg and 0.0237 mg/kg, respectively. Oliceridine at 0.0237 mg/kg provides safe and effective anesthesia when combined with propofol.

    Keywords: oliceridine, propofol, hysteroscopy, effective dose, ED50, ED95

    Download Article[PDF]